2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels.
作者:
主题词
5-甲基胞嘧啶(5-Methylcytosine);老年人(Aged);老年人, 80以上(Aged, 80 and over);女(雌)性(Female);戊二酸盐类(Glutarates);人类(Humans);异柠檬酸脱氢酶(Isocitrate Dehydrogenase);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);男(雄)性(Male);突变(Mutation);肿瘤, 残余(Neoplasm, Residual);预后(Prognosis);缓解诱导(Remission Induction);治疗结果(Treatment Outcome)
DOI
10.3109/10428194.2012.701009
PMID
22680765
发布时间
2021-10-21
- 浏览70

Leukemia & lymphoma
408-10页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文